Opiate modulation of IL-1α, IL-2, and TNF-α transport across the blood-brain barrier

Brain, Behavior, and Immunity

Volumn 22, Issue 7, 2008, Pages 1096-1102

  Lynch, Jessica L ^a   Banks, William A ^a  

^a GRECC   (United States)

Author keywords

Blood brain barrier; Interleukin 1; Interleukin 2; Morphine; Tumor necrosis factor

Indexed keywords

INTERLEUKIN 1ALPHA; INTERLEUKIN 2; MORPHINE; NALTREXONE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ARTICLE; BLOOD BRAIN BARRIER; BLOOD VESSEL PERMEABILITY; CONTROLLED STUDY; IMMUNOMODULATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN TRANSPORT;

ANALGESICS, OPIOID; ANIMALS; BIOLOGICAL TRANSPORT; BLOOD-BRAIN BARRIER; BRAIN; CAPILLARY PERMEABILITY; CYTOKINES; INJECTIONS, INTRAPERITONEAL; INTERLEUKIN-1ALPHA; INTERLEUKIN-2; MALE; MICE; MICE, INBRED ICR; MORPHINE; TIME FACTORS; TISSUE DISTRIBUTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 50249120135     PISSN: 08891591     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbi.2008.04.004     Document Type: Article

References (67)

1. Alonso R., Chaudieu I., Diorio J., Krishnamurthy A., Quirion R., and Boksa P. Interleukin-2 modulates evoked release of [3H]dopamine in a rat cultured mesencephalic cells. Journal of Neurochemistry 61 (1993) 1284-1290
2. Aquilante C.L., Letrent S.P., Pollack G.M., and Brouwer K.L. Increased brain P-glycoprotein in morphine tolerant rats. Life Sciences 66 (2000) PL47-PL51
3. Banks W.A., Farr S.A., La Scola M.E., and Morley J.E. Intravenous human interleukin-1a impairs memory processing in mice: Dependence on blood-brain barrier transport into posterior division of the septum. Journal of Pharmacology and Experimental Therapeutics 299 (2001) 536-541
4. Banks W.A. Enhanced leptin transport across the blood-brain barrier by α1-adrenergic agents. Brain Research 899 (2001) 209-217
5. Banks W.A., Kastin A.J., and Broadwell R.D. Passage of cytokines across the blood-brain barrier. Neuroimmunomodulation 2 (1995) 241-248
6. Banks W.A., Kastin A.J., Harrison L.M., and Zadina J.E. Perinatal treatment of rats with opiates affects the development of the blood-brain barrier transport system PTS-1. Neurotoxicology Teratology 18 (1996) 711-715
7. Banks W.A., Kastin A.J., Fischman A.J., Coy D.H., and Strauss S.L. Carrier-mediated transport of enkephalins and N-Tyr-MIF-1 across blood-brain barrier. American Journal of Physiology 251 (1986) E477-E482
8. Banks W.A., Niehoff M.L., and Zalcman S. Permeability of the mouse blood-brain barrier to murine interleukin-2: predominance of a saturable efflux system. Brain, Behavior, and Immunity 18 (2004) 434-442
9. Banks W.A., Ortiz L., Plotkin S.R., and Kastin A.J. Human interleukin (IL) 1α, murine IL-1α and murine IL-1β are transported from blood to brain in the mouse by a shared saturable mechanism. Journal of Pharmacology and Experimental Therapeutics 259 (1991) 988-996
10. Bian T.H., Wang X.F., and Li X. Effect of morphine on interleukin-1 and tumor necrosis factor α production from mouse peritoneal macrophages in vitro. Acta Physiologica Scandinavica 16 5 (1995) 449-451
11. Bianchi M., and Panerai A.E. Peripherally administered IL-1α interferes with scopolomine-induced amnesia in mice. Cognitive Brain Research 1 (1993) 257-259
12. Blasberg R.G., Fenstermacher J.D., and Patlak C.S. Transport of α-aminoisobutyric acid across brain capillary and cellular membranes. Journal of Cerebral Blood Flow and Metabolism 3 (1983) 8-32
13. Bradbury M.W.B., and Brondsted H.E. Sodium-dependent transport of sugars and iodide from the cerebral ventricles of the rabbit. Journal of Physiology (London) 234 (1973) 127-143
14. Brightman M.W., and Reese T.S. Junctions between intimately apposed cell membranes in the vertebrate brain. Journal of Cell Biology 40 (1969) 648-677
15. Brown S.M., Stimmel B., Taub R.N., and Kochwa S. Immunological dysfunction in heroin addicts. Archives of Internal Medicine 134 (1974) 1001-1006
16. Bussiere J.L., Adler M.A., Rogers T.J., and Eisenstein T.K. Differential effects of morphine and naltrexone on the antibody response in various mouse strains. Immunopharmacology and Immunotoxicology 14 (1992) 657-673
17. Chi O.Z., Lee D.I., Liu X., and Weiss H.R. The effects of morphine on blood-brain barrier disruption caused by intracarotid injection of hyperosmolar mannitol in rats. Anesthesia and Analgesia 90 (2000) 603-608
18. Chishty M., Rechel A., Siva J., Abbott N.J., and Begley D.J. Affinity for the P-glycoprotein efflux pump at the blood-brain barrier may explain the lack of CNS side-effects of modern antihistimines. Journal of Drug Targeting 9 (2001) 223-228
19. Dower S.K., Kronheim S.R., Hopp T.P., Cantrel M., Deely M., Gillis S., Henney C.S., and Urdal D.L. The cell surface receptors for interleukin-1α and interleukin-1β are identical. Nature 324 (1986) 266-268
20. Drach J., Gsur A., Hamilton G., Zhao S., Angerler J., Fiegl M., Zojer N., Raderer M., Haberl I., Andreeff M., and Huber H. Involvement of P-glycoprotein in the transmembrane transport of interleukin-2 (IL-2), IL-4, and interferon-gamma in normal human T lymphocytes. Blood 88 (1996) 1747-1754
21. Fabry Z., Fitzsimmons K.M., Herlein J.A., Moninger T.O., Dobbs M.B., and Hart M.N. Production of the cytokines interleukin 1 and 6 by murine brain microvessel endothelium and smooth muscle pericytes. Journal of Neuroimmunology 47 (1993) 23-34
22. Feng P., Meissler Jr. J.J., Adler M.W., and Eisenstein T.K. Morphine withdrawal sensitizes mice to lipopolysaccharide; elevated TNF-alpha and nitric oxide with decrease IL-12. Journal of Neuroimmunology 164 (2005) 57-65
23. Fiala A.M., Gan X.H., Newton T., Chiappelli F., Shapshak P., Kermaini V., Kung M.A., Diagne A., Martinez O., Way D., Weinand M., Witte M., and Graves M. Divergent effects of cocaine on cytokine production by lymphocytes and monocyte/macrophages: HIV-1 enhancement by cocaine within the blood-brain barrier. Advances in Experimental Medicine and Biology 402 (1996) 145-156
24. Fiala M., Gan X.H., Zhang L., House S.D., Newton T., Graves M.C., Shapshak P., Kim K.S., Witte M., and Chang S.L. Cocaine enhances monocyte migration across the blood-brain barrier. Cocaine's connection to AIDS dementia and vasculitis?. Advances in Experimental Medicine and Biology 437 (1998) 199-205
25. Gan X., Zhang L., Berger O., Stins M.F., Way D., Taub D.D., Chang S.L., Kim K.S., House S.D., Weinand M., Witte M., Graves M.C., and Fiala M. Cocaine enhances brain endothelial adhesion molecules and leukocyte migration. Clinical Immunology 437 (1999) 68-76
26. Gutierrez E.G., Banks W.A., and Kastin A.J. Murine tumor necrosis factor alpha is transported from blood to brain in the mouse. Journal of Neuroimmunology 47 (1993) 169-176
27. Hanisch U.-K., Neuhaus J., Rowe W., van Rossum D., Moller T., Kettenmann H., and Quirion R. Neurotoxic consequences of central long-term administration of interleukin-2 in rats. Neuroscience 79 (1997) 799-818
28. Hubbard A.N., and Cohn Z.A. The enzymatic iodination of the red cell membrane. Journal of Cell Biology 55 (1972) 390-405
29. Kastin A.J., Akerstrom V., and Pan W. Activation of urocortin transport into brain by leptin. Peptides 21 (2000) 1811-1817
30. Kent S., Bluthe R.M., Dantzer R., Hardwick A.J., Kelley K.W., Rothwell N.J., and Vannice J.L. Different receptor mechanisms mediate the pyrogenic and behavioral effects of interleukin 1. Proceedings of the National Academy of Sciences of the United States of America 89 (1992) 9117-9120
31. Kent S., bret-Dibat J.L., Kelley K.W., and Dantzer R. Mechanisms of sickness-induced decreases in food-motivated behavior. Neuroscience and Biobehavioral Reviews 20 (1996) 171-175
32. Konsman J.P., Drukarch B., and van Dam A.M. (Peri)vascular production and action of proinflammatory cytokines in brain pathology. Annals of the New York Academy of Sciences (2007) 1-25
33. Krueger J.M., Obal F.J., Fang J., Kubota T., and Taishi P. The role of cytokines in physiological sleep regulation. Annals of the New York Academy of Sciences 933 (2001) 211-221
34. Langhans W., and Hrupka B. Interleukins and tumor necrosis factor as inhibitors of food intake. Neuropeptides 33 (1999) 415-424
35. Lapchak P.A. A role for interleukin-2 in the regulation of striatal dopaminergic function. Neuroreport 3 (1992) 165-168
36. Layon J., Idris A., Warzynski M., Sherer R., Brauner D., Patch O., McCulley D., and Orris P. Altered T-lymphocyte subsets in hospitalized intravenous drug abusers. Archives of Internal Medicine 144 (1984) 1376-1380
37. Liu H.C., Anday J.K., House S.D., and Chang S.L. Dual effects of morphine on permeability and apoptosis of vascular endothelial cells: morphine potentiates lipopolysaccharide-induced permeability and apoptosis of vascular endothelial cells. J. Neuroimmunol. 146 (2004) 13-21
38. Mohanakumar K.P., and Sood P.P. Inhibitory action of morphine on adenosine triphosphatase content in the whole and individual nuclei of mouse brain during the tolerance-dependence development and its reversal by naloxone. Journal fur Hirnforschung 26 (1985) 695-708
39. Nair M.P., Laing TJ., and Schwartz S.A. Decreased natural and antibody-dependent cellular cytotoxic activities in intravenous drug abusers. Clinical Immunology and Immunopathology 38 (1986) 68-78
40. Neuwelt E., Abbot N.J., Abrey L., Banks W.A., Blakley B., Davis T., Engelhardt B., Grammas P., Nedergaard M., Nutt J., Pardgridge W., Rosenberg G.A., Smith Q., and Drewes L.R. Strategies to advance translational research into brain barriers. Lancet Neurology 7 (2008) 84-96
41. Pan W., Akerstrom V., Zhang J., Pejovic V., and Kastin A.J. Modulation of feeding-related peptide/protein signals at the blood-brain barrier. Journal of Neurochemistry 90 (2004) 455-461
42. Patlak C.S., Blasberg R.G., and Fenstermacher J.D. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. Journal of Cerebral Blood Flow and Metabolism 3 (1983) 1-7
43. Pauli S., Linthorst A.C., and Reul J.M. Tumour necrosis factor-alpha and interleukin-2 differentially affect hippocampal serotonergic neurotransmission, behavioural activity, body temperature and hypothalamic-pituitary-adrenocortical axis activity in the rat. European Journal of Neuroscience 10 (1998) 868-878
44. Pellis N.R., Harper C., and Dafny N. Suppression of the induction of delayed hypersensitivity in rats by repetitive morphine treatments. Experimental Neurology 93 (1986) 92-97
45. Petitto J.M., McCarthy D.B., Rinker C.M., Huang Z., and Getty T. Modulation of behavioral and neurochemical measures of forebrain dopamine function in mice by species-specific interleukin-2. Neuroimmunomodulation 73 (1997) 183-190
46. Petitto J.M., McNamara R.K., Gendreau P.L., Huang Z., and Jackson A.J. Impaired learning and memory and altered hippocampal neurodevelopment resulting from interleukin-2 gene deletion. Neuroscience Research 56 (1999) 441-446
47. Pretorius H.T., Kastin A.J., and Banks W.A. Binding of Tyr-MIF-1 to isolated brain capillaries. Brain Research Bulletin 17 (1986) 829-831
48. Quan N., and Banks W.A. Brain-immune communication pathways. Brain, Behavior, and Immunity 21 (2007) 727-735
49. Rapoport S.I. Blood Brain Barrier in Physiology and Medicine (1976), Raven Press, New York
50. Roy S., Balasubrmanian S., Sumandeep S., Charboneau R., Wang J., Melnyk D., Beilman G.J., Vatassery R., and Barke R.A. Morphine directs T cells towards T(H2) differentiation. Surgery 130 (2001) 304-309
51. Roy S., Chapin R.B., Cain K.J., Charboneau R.G., Ramakrishnan S., and Barke R.A. Morphine inhibits transcriptional activation of IL-2 in mouse thymocytes. Cellular Immunology 179 (1997) 1-9
52. Roy S., Wang J., Gupta S., Charboneau R., Loh H.H., and Barke R.A. Chronic morphine treatment differentiates T helper cells to Th2 effector cells by modulating transcription factors GATA 3 and T-bet. Journal of Neuroimmunology 147 (2004) 78-81
53. Sacerdote P., di San Secondo V.E., Sirchia G., Manfredi B., and Panerai A.E. Endogenous opioids modulate allograft rejection time in mice: possible relation with Th1/Th2 cytokines. Clinical and Experimental Immunology 113 (1998) 465-469
54. Schneider-Schaulies J., Schneider-Schaulies S., and Ter Meulen V. Differential induction of cytokines by primary and persistent measles virus infections in human glial cells. Virology 195 (1993) 219-228
55. Seihean D., Kobayashi K., He Y., Uchihara T., Rosenblum O., Katlama C., Bricaire F., Duykaerts C., and Hauw J.J. Tumor necrosis factor-alpha, microglia and astrocytes in AIDS dementia complex. Acta Neuropathologica 93 5 (2008) 508-517
56. Shavit Y., Depaulis A., Martin F.C., Terman G.W., Pechnick R.N., Zane C.J., Gale R.P., and Liebeskind J.P. Involvement of brain opiate receptors in the immune-suppressive effect of morphine. Proceedings of the National Academy of Sciences of the United States of America 83 (1986) 7114-7117
57. Sospedra M., and Martin R. Immunology of multiple sclerosis. Annual Review of Immunology 23 (2005) 683-747
58. Spadaro F., and Dunn A.J. Intracerebroventricular administration of interleukin-1 to mice alters investigation of stimuli in a novel environment. Brain, Behavior, and Immunity 4 (1990) 308-322
59. Trancredi V., Zona C., Velotti F., Eusebi F., and Santoni A. Interleukin-2 suppresses established long-term potentiation and inhibits its induction in the rat hippocampus. Brain Research 525 (1990) 149-161
60. Triguero D., Buciak J., and Pardridge W.M. Capillary depletion method for quantification of blood-brain barrier transport of circulating peptides and plasma proteins. Journal of Neurochemistry 54 (1990) 1882-1888
61. Waguespack P.J., Banks W.A., and Kastin A.J. Interleukin-2 does not cross the blood-brain barrier by a saturable transport system. Brain Research Bulletin 34 (1994) 103-109
62. Xiang S., Pan W., and Kastin A.J. Strategies to create a regenerating environment for the injured spinal cord. Current Pharmaceutical Design 11 (2005) 1267-1277
63. Zalcman S., Green-Johnson J.M., Murray L., Wan W., Nance D.M., and Greenberg A.H. Interleukin-2 induced enhancement of an antigen-specific IgM PFC response is mediated by the sympathetic nervous system. Journal of Pharmacology and Experimental Therapeutics 271 (1994) 977-982
64. Zalcman S., Murray L., Dyck D.G., Greenberg A.H., and Nance D.M. Interleukin-2 and -6 induce behavioral-activating effects in mice. Brain Research 811 (1998) 111-121
65. Zalcman S.S. Interleukin-2 potentiates novelty- and GBR 12909-induced exploratory activity. Brain Research 899 (2001) 1-9
66. Zalcman S.S. Interleukin-2-induced increases in climbing behavior: inhibition by dopamine D-1 and D-2 receptor antagonists. Brain Research 944 (2002) 157-164
67. Zhang L., Looney D., Taub D., Chang S.L., Way D., Witte M.H., Graves M.C., and Fiala M. Cocaine opens the blood-brain barrier to HIV-1 invasion. Journal of Neurovirology 4 (1998) 619-626